RT Journal Article
SR Electronic
T1 Individual Preparedness for Distant Wildfires and the Delta Variant in the United States: A Survey of 2,250 US Residents
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.24.21260660
DO 10.1101/2021.07.24.21260660
A1 Devabhaktuni Srikrishna
YR 2021
UL http://medrxiv.org/content/early/2021/08/10/2021.07.24.21260660.abstract
AB Background COVID-19 virus travels in the air and collects indoors through tiny particles from exhaled breath, and remains a growing concern globally especially since case studies of vaccine breakthrough infections are being reported. Last year’s wildfires resulted in the worst air quality on record in the Western US due to toxic wildfire smoke (PM 2.5 pollution) traveling from distant wildfires and this year can potentially be even worse due to extremely dry conditions. Aerosol precautions such as high-filtration (Hi-Fi) masks and HEPA air purifiers are useful to effectively reduce inhalation of most of these toxic aerosols. Whereas the lack of fit or filtration in a mask or use of an air purifier of insufficient size (capacity) for the room can inadvertently render these precautions ineffective. Here we investigate the public’s concerns about wildfires and the COVID-19 variants (e.g. delta), their use of aerosol precautions, and whether these are being done in an effective manner.Methods We conducted a national survey of 2,250 US residents in order to understand public concerns about airborne threats and their usage of airborne (aerosol) precautions.Results We find over 66% of US residents surveyed are worried about inhaling COVID-19 and its variants, and 52% are worried about toxic wildfire particles in the air. In the mountain and pacific regions the latter rises to 73%. Only a quarter are using masks with higher filtration and high level of fit (or Hi-Fi masks e.g. N95 or similar such as elastomeric N95 or KF94). Two-thirds are still using loose-fitting cloth or surgical masks. Just over 40% of respondents report using air purifiers at home, and of this group only 40% use it in their bedroom where they sleep. Of those using air purifiers, the majority said they chose the size of their air purifier based on “most popular” models, “recommendations,” or “reviews.” However, of those using air purifiers only 42% reported doing a calculation (or using a calculator) to estimate the right size of air purifier needed for the room they are using it in. Notably, a much higher percentage of people (than average) reported use of Hi-Fi masks and home air purifiers in certain occupations such as doctors, healthcare, first responders, public safety, engineering, military, and construction.Conclusion National survey data suggests most US residents are worried about wildfire smoke and Covid variants (e.g. delta variant) but a majority are not prepared for it. Preparation with aerosol precautions will also be useful for future pandemics and national biodefense.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNone.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was granted for the study by Patient Knowhow's Ethics Oversight Body after the Methods section was updated to answer questions about incentives for survey participants, relationship to the author, sponsorship of the survey, and survey completion rates. Ethics Oversight Body: Dr. Vikas Duvvuri, MD, Phd President, Sunol Hills, LLC Regional CMO/Medical Director, UHS Consultant, Patient Knowhow, Inc. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDue to the nature of this survey data collection method, participants of this survey did not agree for individual response data to be shared publicly, so supporting data is not available.